PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
David Malka, MD, PhD - Let’s Get Personal: Effective and Individualised Management of Targeted Therapies in Cholangiocarcinoma
Visit https://www.peervoice.com/JGH860 to view the entire programme with slides. After completing “David Malka, MD, PhD - Let’s Get Personal: Effective and Individualised Management of Targeted Therapies in Cholangiocarcinoma”, participants will be able to: Evaluate current evidence-based treatment options in patients with cholangiocarcinoma (CCA) who have actionable mutations, with a focus on FGFR2 alterations; Identify key clinical challenges encountered in the targeted treatment of FGFR2-fusion–positive CCA; and Formulate personalised management plans for patients with CCA who are treated with FGFR inhibitors.